Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Chantal Mourton Gilles"'
Autor:
Aroa Relaño-Ginès, Audrey Gabelle, Claire Hamela, Maxime Belondrade, Danielle Casanova, Chantal Mourton-Gilles, Sylvain Lehmann, Carole Crozet
Publikováno v:
PLoS Pathogens, Vol 9, Iss 8, p e1003485 (2013)
Prion diseases are irreversible progressive neurodegenerative diseases, leading to severe incapacity and death. They are characterized in the brain by prion amyloid deposits, vacuolisation, astrocytosis, neuronal degeneration, and by cognitive, behav
Externí odkaz:
https://doaj.org/article/1650d12fd8564677b0b7376c1c8382dc
Autor:
Karine Toupet, Valérie Compan, Carole Crozet, Chantal Mourton-Gilles, Nadine Mestre-Francés, Françoise Ibos, Pierre Corbeau, Jean-Michel Verdier, Véronique Perrier
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2773 (2008)
Classical drug therapies against prion diseases have encountered serious difficulties. It has become urgent to develop radically different therapeutic strategies. Previously, we showed that VSV-G pseudotyped FIV derived vectors carrying dominant nega
Externí odkaz:
https://doaj.org/article/de2058e0f6e44cb7bbbe32769cc10552
Autor:
Chantal Mourton-Gilles, Dorothée Jary, Jean Berthier, Cathy Philippe, Mohamed Lemine Youba Diakite, Jérôme Rollin, Didier Sauvaire, Guillaume Delapierre, Xavier Gidrol
Publikováno v:
Lab on a Chip
Lab on a Chip, Royal Society of Chemistry, 2015, 15 (10), pp.2308-2317. ⟨10.1039/c5lc00178a⟩
Lab on a Chip, 2015, 15 (10), pp.2308-2317. ⟨10.1039/c5lc00178a⟩
Lab on a Chip, Royal Society of Chemistry, 2015, 15 (10), pp.2308-2317. ⟨10.1039/c5lc00178a⟩
Lab on a Chip, 2015, 15 (10), pp.2308-2317. ⟨10.1039/c5lc00178a⟩
A long-sought milestone in the defense against bioterrorism is the development of rapid, simple, and near-patient assays for diagnostic and theranostic purposes. Here, we present a powerful test based on a host response to a biological weapon agent,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e45b2e3561a1f640897c5c1ad397fc0
https://hal.archives-ouvertes.fr/hal-02109816
https://hal.archives-ouvertes.fr/hal-02109816
Publikováno v:
Journal of Neurocytology. 30:145-158
Differential distribution and phosphorylation of tau proteins were studied in developing kitten brain by using several antibodies, and was compared to phosphorylation in Alzheimer's disease. Several antibodies demonstrated the presence of phosphoryla
Autor:
Claire Hamela, Carole Crozet, Danielle Casanova, Maxime Belondrade, Chantal Mourton-Gilles, Aroa Relano-Gines, Sylvain Lehmann, Audrey Gabelle
Publikováno v:
PLoS Pathogens, Vol 9, Iss 8, p e1003485 (2013)
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2013, 9 (8), pp.e1003485. ⟨10.1371/journal.ppat.1003485⟩
PLoS Pathogens, 2013, 9 (8), pp.e1003485. ⟨10.1371/journal.ppat.1003485⟩
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2013, 9 (8), pp.e1003485. ⟨10.1371/journal.ppat.1003485⟩
PLoS Pathogens, 2013, 9 (8), pp.e1003485. ⟨10.1371/journal.ppat.1003485⟩
Prion diseases are irreversible progressive neurodegenerative diseases, leading to severe incapacity and death. They are characterized in the brain by prion amyloid deposits, vacuolisation, astrocytosis, neuronal degeneration, and by cognitive, behav
Autor:
Chantal Mourton-Gilles, André Delacourte, Jacques Hugon, M. Lesort, O. Condamines, Philippe Couratier
Publikováno v:
Neuroscience Letters. 203:155-158
One of the hallmarks of Alzheimer's disease (AD) is neurofibrillary degeneration which results from the aggregation of phosphorylated tau proteins into paired helical filament (PHF) structures. AD2 is a new monoclonal antibody raised against PHF tau
Autor:
Valérie Buée-Scherrer, A. Wattez, Olivier Condamines, André Delacourte, Laurence Boissier, Chantal Mourton-Gilles, Bernard Pau
Publikováno v:
Neuroscience Letters. 192:81-84
Monoclonal antibodies against human paired helical filament tau (PHF-tau) proteins were produced. Two of these antibodies, AD1 and AD2, were shown by immunoblot to be directed against distinct hyperphosphorylated epitopes of the PHF-tau proteins. Usi
Autor:
Guillaume Vicat, Sandra Cobo, Jean-Daniel Abraham, Nicolas Salvetat, Jacques Touchon, Laurence Molina, Sophie Calvayrac-Pawlowski, Bernard-François Michel, Jeannette Fareh, Jean-Michel Verdier, Chantal Mourton-Gilles, Franck Molina
Publikováno v:
Convergence
Convergence, SAGE Publications, 2011, 16 (2), pp.161-71. ⟨10.3109/1354750X.2010.536995⟩
Convergence, SAGE Publications, 2011, 16 (2), pp.161-71. ⟨10.3109/1354750X.2010.536995⟩
International audience; Using proteomic approach in cerebrospinal fluid (CSF) we identified pigment epithelium-derived factor (PEDF) and Haptoglobin (Hp) as putative markers that could discriminate between AD and other dementias. ELISA assays were de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::301ce1b8283fd9779d39cd03d949d72c
https://hal.archives-ouvertes.fr/hal-00636453
https://hal.archives-ouvertes.fr/hal-00636453
Autor:
Corinne Ida Lasmézas, Elisabeth Kremmer, Pierluigi Gambetti, Jacques Grassi, Sabine Gilch, Thierry Baron, Cécile Féraudet, Nicole Salès, Chantal Mourton Gilles, Hermann M. Schätzl, Wen-Quan Zou, Maxime Lefebvre-Roque
Publikováno v:
Prion
Prion, Taylor & Francis, 2007, 1 (3), pp.198-206
Prion, 2007, 1 (3), pp.198-206
Prion, Taylor & Francis, 2007, 1 (3), pp.198-206
Prion, 2007, 1 (3), pp.198-206
The absence of specific immune response is a hallmark of prion diseases. However, in vitro and in vivo experiments have provided evidence that an anti-PrP humoral response could have beneficial effects. Prophylactic passive immunization performed at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32aac3d1074ae93f8e688fdec1ca21eb
https://europepmc.org/articles/PMC2634593/
https://europepmc.org/articles/PMC2634593/
Autor:
Clément Mettling, Chantal Mourton-Gilles, Yea-Lih Lin, Sylvain Lehmann, Carole Crozet, Pierre Corbeau, Véronique Perrier
Publikováno v:
Journal of Cell Science
Journal of Cell Science, 2004, 117 (Pt 23), pp.5591-7. ⟨10.1242/jcs.01484⟩
Journal of Cell Science, Company of Biologists, 2004, 117 (Pt 23), pp.5591-7. ⟨10.1242/jcs.01484⟩
Journal of Cell Science, 2004, 117 (Pt 23), pp.5591-7. ⟨10.1242/jcs.01484⟩
Journal of Cell Science, Company of Biologists, 2004, 117 (Pt 23), pp.5591-7. ⟨10.1242/jcs.01484⟩
This article was highlighted in Nature: research highlight in Nature VOL432, 4 November 2004, page 33. acknowledgments to: Claire Marianni; T. Onodera for Prnp KO cells and J. Grassi for anti-PrP antibodies; Currently, there is no treatment to cure t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89a4bc1d87755c5bd4aaf2eb21e8f62
https://www.hal.inserm.fr/inserm-00143203/document
https://www.hal.inserm.fr/inserm-00143203/document